共 50 条
- [32] Everolimus-based, calcineurin-inhibitor-free regimen in recipients of de-novo kidney transplants: an open-label, randomised, controlled trial (vol 377, pg 837, 2011) [J]. LANCET, 2012, 380 (9858): : 1994 - 1994
- [34] Everolimus Initiation With Calcineurin Inhibitor Withdrawal Reduces Allograft Vasculopathy in De-Novo Heart Transplant Recipients [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2014, 33 (04): : S154 - S154
- [35] Prospective Study of Everolimus With Calcineurin Inhibitor-Free Immunosuppression After Heart Transplantation: Results at Four Years [J]. ANNALS OF THORACIC SURGERY, 2014, 97 (03): : 888 - 893
- [37] Treatment of De Novo Renal Transplant Recipients With Calcineurin Inhibitor-free, Belatacept Plus Everolimus-based Immunosuppression [J]. TRANSPLANTATION DIRECT, 2023, 9 (02): : E1419
- [39] Everolimus de novo in liver transplantation [J]. GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2009, 33 : S247 - S252